Morgan Stanley raised the firm’s price target on Paychex (PAYX) to $137 from $133 and keeps an Equal Weight rating on the shares. Amid “a more conservative underwriting posture in the insurance agency” and events like hurricanes in Florida, Paychex “continues to execute well,” the analyst tells investors. Short interest had moderated of late, implying that a slight Q2 beat and FY25 outlook reiteration was “likely enough for shares to work on the print so long as out-of-business rates remained stable” and “that dynamic played out as anticipated,” the analyst added.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAYX:
- Paychex Reports Strong Q2 Revenue and Earnings Growth
- Morning Movers: Lamb Weston tanks after second quarter results and CEO change
- Paychex reports Q2 adjusted EPS $1.14, consensus $1.12
- Options Volatility and Implied Earnings Moves Today, December 19, 2024
- Notable companies reporting before tomorrow’s open